10 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 1, 3 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Triazolam: new trials by email Literature Review of Triazolam trials Research Report on Triazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects Triazolam and TS-172, TS-172 and itraconazole - Healthy Male Subjects | Phase 1 | Completed | Taisho Pharmaceutical Co., Ltd. | 30 | 2025-03-11 | 2025-05-15 |
| Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal Buspirone 10 Mg Oral Tablet, Triazolam 0.25 MG Oral Tablet, Placebo oral tablet - Anxiety | Not applicable | Recruiting | University of Manitoba | 42 | 2023-10-16 | 2026-02-18 |
| Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient Midazolam Hydrochloride 2Mg/mL Syrup, Triazolam 0.125 MG - Dental Anxiety | Not applicable | Completed | University of Pittsburgh | 4 | 2018-01-26 | 2018-06-19 |
| Oral Versus Intravenous Sedation for Ocular Procedures Triazolam, Midazolam, Microcrystalline Cellulose - Surgery, Sedation | Phase 4 | Completed | Boston Medical Center | 327 | 2017-10-16 | 2020-08-19 |
| Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents Methylphenidate, Triazolam, Project: EVO - Healthy | Not applicable | Completed | Akili Interactive Labs, Inc. | 18 | 2016-07-01 | 2016-11-07 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers Gabapentin, Diphenhydramine citrate, Triazolam - Healthy | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 59 | 2013-07-29 | 2021-02-21 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants Esketamine, Placebo, Triazolam - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 58 | 2012-12-01 | 2013-08-09 |
| A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects triazolam liquid oral drops, triazolam tablets - Healthy | Phase 1 | Completed | Pfizer | 34 | 2011-09-01 | 2016-10-24 |
| Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption Triazolam - Healthy Volunteers | Phase 1 | Withdrawn | Pfizer | 2010-08-01 | 2016-04-06 | |
| Physiological, Behavioral and Subjective Effects of Drugs (GHB) sodium oxybate, triazolam and pentobarbital - Sedative Abuse | Phase 1 | Completed | Orphan Medical | 20 | 2003-08-01 | 2008-09-10 |
| Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse Ramelteon, triazolam, and placebo (56 possible combinations total) - Drug Abuse | Phase 2 | Completed | Takeda | 14 | 2003-06-01 | 2012-02-28 |
| Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine GABA Agonists - Cocaine-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 78 | 2001-08-01 | 2017-01-11 |
Anxiety Disorders (2) · Behavior, Addictive (1) · Cocaine-Related Disorders (1) · Dementia (1) · Depression (1) · Psychophysiologic Disorders (1) · Schizophrenia (1) · Sleep Initiation and Maintenance Disorders (1) · Substance-Related Disorders (1)
Pfizer (2) · Akili Interactive Labs, Inc. (1) · Boston Medical Center (1) · Hannover Medical School (1) · Janssen Research & Development, LLC (1) · National Institute on Drug Abuse (NIDA) (1) · Orphan Medical (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Taisho Pharmaceutical Co., Ltd. (1) · Takeda (1) · University of Manitoba (1) · University of Pittsburgh (1)
United States (7) · Belgium (2) · Canada (1) · Germany (1) · Japan (1)
Craig Rush (1) · Helge Frieling, Prof., MD (1) · Manju Subramanian, MD (1) · Roland Griffiths, PhD (1) · Ted Riley (1) · Whitney Eichholz, DDS (1)